Literature DB >> 3485022

The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.

A P Weetman, D J Volkman, K D Burman, J B Margolick, P Petrick, B D Weintraub, A S Fauci.   

Abstract

Although the thyroid gland itself is a major site of the autoimmune response, the study of T-cell function in autoimmune thyroid disease has usually relied on peripheral blood as a source of cells. In this study, we have established thyroid-derived T-cell lines from six patients with Graves' disease and one patient with Hashimoto's thyroiditis by culturing the thyroid lymphocytes on an autologous thyroid follicular cell monolayer in the presence of exogenous interleukin 2 (IL-2). These T-cell lines have allowed in vitro investigation of thyroid-derived T-cell function, an approach which was previously limited by the number of lymphocytes obtained from the gland. The lines were predominantly OKT3, OKT4, and HLA-DR positive but showed heterogeneous proliferative responses. Some lines gave autologous or allogeneic mixed lymphocyte reactions but other did not. Only one of the seven lines responded well to the thyroid antigens thyroglobulin and microsomes presented by autologous monocytes. However, six of the lines proliferated in the presence of live but not dead autologous thyroid follicular cells, particularly when interferon-gamma (IFN-gamma) was added. This treatment has been shown to enhance HLA-DR and -DQ antigen expression by thyroid follicular cells in vitro. Furthermore, the proliferation induced by IFN-gamma-treated thyroid follicular cells was increased when thyroglobulin was also added. Together these results support the hypothesis that the expression of Ia antigens such as HLA-DR by thyroid follicular cells in autoimmune thyroid disease may be important in enhancing the autoimmune response, conferring on these cells the ability to present thyroid autoantigens to T cells. The use of thyroid-derived T-cell lines should permit a more detailed evaluation of the disordered immuno-regulation in Graves' disease and Hashimoto's thyroiditis than has been possible previously.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485022     DOI: 10.1016/0090-1229(86)90213-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

1.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells.

Authors:  I Todd; L J Hammond; R F James; M Feldmann; G F Bottazzo
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 2.  Regulation and role of thyroid cell class II antigen expression.

Authors:  A P Weetman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells.

Authors:  Z Wu; P A Biro; R Mirakian; L Hammond; F Curcio; F S Ambesi-Impiombato; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; Y Ueki; T Fukuda; M Matsunaga; C Shimomura; N Ishikawa; H Tezuka; H Nakao
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

6.  Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.

Authors:  G F Del Prete; A Tiri; S Mariotti; A Pinchera; M Ricci; S Romagnani
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.

Authors:  C M Dayan; M Londei; A E Corcoran; B Grubeck-Loebenstein; R F James; B Rapoport; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.

Authors:  B Grubeck-Loebenstein; M Londei; C Greenall; K Pirich; H Kassal; W Waldhäusl; M Feldmann
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

9.  CD4 cells from patients with autoimmune thyroid disease secrete interferon gamma after stimulation by thyroid microsomal antigen; CD8 cells suppress this secretion.

Authors:  Y Sakatsume; S Matsubayashi; Y Kasuga; M Iitaka; Y Iwatani; R Volpé
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

10.  T cell responses to synthetic TSH receptor peptides in Graves' disease.

Authors:  N Tandon; M A Freeman; A P Weetman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.